Today: 21 April 2026
Subscribe
Browse Category

NASDAQ:CYTK 30 August 2025 - 1 January 2026

Cytokinetics (CYTK) stock ends 2025 higher as Myqorzo launch nears — what’s next

Cytokinetics (CYTK) stock ends 2025 higher as Myqorzo launch nears — what’s next

Cytokinetics shares closed 2025 up 3.5% at $63.54 after FDA cleared Myqorzo for obstructive hypertrophic cardiomyopathy. The drug, set to launch in January under a REMS program and boxed warning, will compete with Bristol Myers Squibb’s Camzyos. Chief Commercial Officer Andrew Callos sold 1,809 shares at $62.44 each on Dec. 29 under a pre-arranged plan. U.S. markets reopen Friday after the New Year’s holiday.
1 January 2026
····
Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

Cytokinetics shares climbed 3.7% to $63.63 Wednesday, bucking a weaker market as investors awaited Myqorzo’s U.S. launch in January. A Form 4 showed Chief Commercial Officer Andrew Callos sold 1,809 shares at $62.44 on Dec. 29 under a pre-set plan. The drug, approved this month, will be distributed with a REMS safety program. Investors are watching for pricing details and initial uptake.
31 December 2025
··
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

BioMarin agreed to acquire Amicus Therapeutics for $4.8 billion on Dec. 19, paying a 33% premium and adding two rare-disease drugs with $599 million in combined annual sales. The deal, plus an FDA approval for Cytokinetics and new IPO filings, drove biotech stocks higher ahead of the Christmas-shortened trading week. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·····
Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

The FDA approved Leqembi IQLIK, the first at-home injectable Alzheimer’s treatment, enabling weekly self-administered doses. U.S. regulators also cleared Sanofi’s Wayrilz, the first BTK inhibitor for chronic immune thrombocytopenia. Cytokinetics’ aficamten outperformed metoprolol in a Phase 3 heart drug trial. WHO warned Gaza has run out of critical medical supplies amid a spike in Guillain-Barré syndrome cases.
30 August 2025
····

Stock Market Today

  • 3 Russell 2000 Stocks Showing Red Flags and Alternative Picks
    April 21, 2026, 6:52 AM EDT. The Russell 2000 index, focusing on small-cap firms, features Energy Recovery (ERII), Allient (ALNT), and Merit Medical Systems (MMSI) as stocks with warning signs. ERII faces slowing revenue growth, a forecasted 12.7% sales drop, and declining returns on capital. ALNT reports a 2.1% annual sales decline and falling earnings per share (EPS), signaling management challenges. MMSI struggles with scale and delivers a low 5.1% return on capital amid stiff competition. Valuations are 16.4x, 28.3x, and 17.6x forward price-to-earnings (P/E) respectively, raising concerns. Investors may find better potential in top momentum stocks with strong fundamentals and near-term upward trends, suggesting caution in these highlighted names.

Latest article

Australia Stock Market Today: ASX 200 Stalls as Rio Tinto Gain Runs Into Energy Selloff

Australia Stock Market Today: ASX 200 Stalls as Rio Tinto Gain Runs Into Energy Selloff

21 April 2026
Australian shares closed nearly flat Tuesday, with the S&P/ASX 200 down 3.9 points to 8,949.40 as investors awaited U.S.-Iran talks. Rio Tinto rose after reporting a 9% jump in first-quarter copper-equivalent output, but energy stocks fell. Brent crude traded near $95 a barrel, and the Australian dollar slipped to $0.715. ANZ reported consumer confidence at 64.3, near record lows, with inflation expectations at 7.1%.
FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

21 April 2026
The FTSE 100 rose 0.12% to 10,622.06 in delayed London trade Tuesday, while the FTSE 250 gained 0.39%. British Land climbed after boosting earnings guidance and signing Anthropic as a tenant. Associated British Foods fell on plans to split Primark from its food units and a profit warning. Crest Nicholson plunged nearly a third after cutting its outlook and warning on home completions.
US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

21 April 2026
U.S. stock index futures rose early Tuesday, with Nasdaq 100 futures up 0.3% and Dow futures gaining 61 points, as investors weighed AI gains against Middle East tensions. Amazon announced up to $25 billion in new investment in Anthropic, while Apple said Tim Cook will step down as CEO in September, succeeded by John Ternus. The U.S. Census Bureau will release March retail sales data at 8:30 a.m. EDT.
Go toTop